Annual Securities Report — FY2025
What OncoTherapy Science,Inc. reported for the period from 2025-04-01 to 2026-03-31.
Filed 2026-06-23View the original on EDINET
How much it says
39Thin
What moved here
14named for the first time
Its own wording
31terms
Which filing this is
35/ 35newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist
The Annual Securities Report describes continued operations and research and development in cancer genomic analysis and drug discovery, with consolidated business revenue of ¥808 million and an operating loss of ¥810 million for the fiscal year. It also states that cash and deposits increased through the exercise of stock acquisition rights and financing, including the 38th Series of Stock Acquisition Rights with an exercise-price adjustment clause.
Komori's summary of this document, not the document's own words.39Thin
How much this filing saysA weighted roll-up of 11 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 36 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
76
Very detailed
38
Thin
30
Thin
75
Very detailed
0
Almost nothing
0
Almost nothing
27
Almost nothing
62
Detailed
13
Almost nothing
55
Typical
50
Typical
R&D spend5億円Money spent making new things.
Cash left over-10億円Cash from the business, less what went into equipment.
Spent on equipment63百万円Plants, machines — things meant to last.
Employees46Headcount at the end of this period.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.